14-day Premium Trial Subscription Try For FreeTry Free
$25.38
+0.0200 (+0.0789%)
At Close: May 02, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $14.00 $25.47 Thursday, 2nd May 2024 DCPH stock ended at $25.38. This is 0.0789% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 0.493% from a day low at $25.35 to a day high of $25.47.
90 days $13.86 $25.47
52 weeks $9.90 $25.47

Historical Deciphera Pharmaceuticals Inc prices

Date Open High Low Close Volume
Jun 09, 2023 $13.99 $14.10 $13.67 $14.02 462 210
Jun 08, 2023 $13.88 $14.13 $13.58 $13.98 442 655
Jun 07, 2023 $14.11 $14.22 $13.61 $13.87 324 491
Jun 06, 2023 $14.45 $14.59 $14.08 $14.14 361 580
Jun 05, 2023 $13.99 $14.59 $13.77 $14.42 504 710
Jun 02, 2023 $13.89 $14.10 $13.57 $14.08 335 697
Jun 01, 2023 $13.40 $13.86 $13.30 $13.76 256 422
May 31, 2023 $13.63 $14.30 $13.38 $13.50 531 081
May 30, 2023 $13.78 $14.04 $13.43 $13.60 306 561
May 26, 2023 $13.68 $14.05 $13.64 $13.79 282 843
May 25, 2023 $14.42 $14.43 $14.00 $14.00 424 134
May 24, 2023 $14.42 $14.49 $14.13 $14.47 307 655
May 23, 2023 $14.32 $14.66 $14.25 $14.49 486 607
May 22, 2023 $14.80 $14.95 $14.22 $14.32 676 155
May 19, 2023 $14.05 $14.95 $14.04 $14.78 858 810
May 18, 2023 $13.79 $13.98 $13.54 $13.89 491 601
May 17, 2023 $13.71 $13.88 $13.53 $13.80 550 161
May 16, 2023 $13.90 $14.02 $13.62 $13.68 509 991
May 15, 2023 $14.09 $15.06 $14.08 $14.22 499 856
May 12, 2023 $13.80 $13.99 $13.58 $13.77 280 349
May 11, 2023 $13.79 $13.82 $13.49 $13.75 382 771
May 10, 2023 $14.16 $14.25 $13.46 $13.76 370 974
May 09, 2023 $13.41 $13.93 $13.34 $13.92 572 729
May 08, 2023 $13.60 $13.82 $13.43 $13.56 508 046
May 05, 2023 $13.23 $13.85 $13.27 $13.52 622 814
Click to get the best stock tips daily for free!

About Deciphera Pharmaceuticals Inc

Deciphera Pharmaceuticals Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. Th... DCPH Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT